Media Summary: J. Paul Phillips provides an overview of the FDA's Jinsy Andrews, MD of NYU Langone Health was joined by Benjamin Greenberg, MD, MHS, FAAN of Clene Nanomedicine to ... Co-sponsored by CUPA, the University of Arizona Health Law & Policy Program and the American Society of Law, Medicine ...

Expanded Access Webinar - Detailed Analysis & Overview

J. Paul Phillips provides an overview of the FDA's Jinsy Andrews, MD of NYU Langone Health was joined by Benjamin Greenberg, MD, MHS, FAAN of Clene Nanomedicine to ... Co-sponsored by CUPA, the University of Arizona Health Law & Policy Program and the American Society of Law, Medicine ... James Berry, MD, MPH of Massachusetts General Hospital was joined by representatives from Rapa Therapeutics to provide an ... Suma Babu, MBBS, MPH of Massachusetts General Hospital presented news and updates about An overview on the submission process for emergency and non-emergency

Photo Gallery

Expanded Access Webinar
Expanded Access
Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers
Expanded Access Care Webinar
Expanded Access Part 1: Introduction
Overview of FDA's Expanded Access Program (13/14) REdI 2017
Healey Community Q&A Webinar: March 12, 2026 | CNM-Au8 Expanded Access Update
What is Expanded Access?
Perspectives on Real-World Data/Evidence Collection Through Expanded Access During COVID-19.
Healey Community Q&A Webinar: February 12, 2026 | Expanded Access
HEALEY ALS Platform Trial Webinar: September 12, 2024 | Expanded Access Update with Dr. Babu
Expanded Access Part 2: How to Submit a Single Patient IND
View Detailed Profile
Expanded Access Webinar

Expanded Access Webinar

Expanded Access

Expanded Access

Expanded Access

Expanded access

Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers

Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers

This

Expanded Access Care Webinar

Expanded Access Care Webinar

An introduction to and overview on the

Expanded Access Part 1: Introduction

Expanded Access Part 1: Introduction

What is

Overview of FDA's Expanded Access Program (13/14) REdI 2017

Overview of FDA's Expanded Access Program (13/14) REdI 2017

J. Paul Phillips provides an overview of the FDA's

Healey Community Q&A Webinar: March 12, 2026 | CNM-Au8 Expanded Access Update

Healey Community Q&A Webinar: March 12, 2026 | CNM-Au8 Expanded Access Update

Jinsy Andrews, MD of NYU Langone Health was joined by Benjamin Greenberg, MD, MHS, FAAN of Clene Nanomedicine to ...

What is Expanded Access?

What is Expanded Access?

This week's briefing focuses on

Perspectives on Real-World Data/Evidence Collection Through Expanded Access During COVID-19.

Perspectives on Real-World Data/Evidence Collection Through Expanded Access During COVID-19.

Co-sponsored by CUPA, the University of Arizona Health Law & Policy Program and the American Society of Law, Medicine ...

Healey Community Q&A Webinar: February 12, 2026 | Expanded Access

Healey Community Q&A Webinar: February 12, 2026 | Expanded Access

James Berry, MD, MPH of Massachusetts General Hospital was joined by representatives from Rapa Therapeutics to provide an ...

HEALEY ALS Platform Trial Webinar: September 12, 2024 | Expanded Access Update with Dr. Babu

HEALEY ALS Platform Trial Webinar: September 12, 2024 | Expanded Access Update with Dr. Babu

Suma Babu, MBBS, MPH of Massachusetts General Hospital presented news and updates about

Expanded Access Part 2: How to Submit a Single Patient IND

Expanded Access Part 2: How to Submit a Single Patient IND

An overview on the submission process for emergency and non-emergency

Clinical Trials Webinar 3: Expanded Access Programs (EAP)

Clinical Trials Webinar 3: Expanded Access Programs (EAP)

This is the third